Charles Mathews

Filings by Charles Mathews span 2 companies, the busiest being Avanir Pharmaceuticals and Apollo Endosurgery, Inc. We count 15 filings; the first trade dates from 13 February 2006 and the latest from 9 March 2016.

No open-market sale appears; the market trades are 2 purchases worth €29k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 9 share grants and 4 option exercises.

The newest entry dates from 16 March 2016: an option exercise, in Apollo Endosurgery, Inc. The latest purchase dates back some time: it was published 5,072 days ago, on 20 December 2012. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.